Clinical Trials · NCT07835360

Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes

Phase
N/A
Recruitment status
Recruiting
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Enrollment
200
Start date
Jul 2026
Locations
2 sites, Mexico
Primary endpoint
Change in Appendicular Lean Mass
View Tirzepatide compound reference